ArticlePloS one2021

Short-term efficacy and safety of second generation bipolar transurethral vaporization of the prostate (B-TUVP) for large benign prostate enlargement: Results from a retrospective feasibility study.

Takeshi Fukazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.